Brookfield Corp’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,319
Closed -$992K 212
2023
Q2
$992K Sell
17,319
-136,447
-89% -$7.96M ﹤0.01% 465
2023
Q1
$9.27M Buy
+153,766
New +$9.39M 0.04% 183
2022
Q4
Sell
-152,579
Closed -$8.72M 616
2022
Q3
$8.72M Buy
+152,579
New +$8.89M 0.03% 183
2022
Q2
Sell
-51,099
Closed -$2.94M 628
2022
Q1
$2.94M Buy
51,099
+21,099
+70% +$1.08M 0.01% 343
2021
Q4
$1.42M Buy
30,000
+10,000
+50% +$455K 0.01% 389
2021
Q3
$842K Buy
+20,000
New +$865K ﹤0.01% 441
2021
Q1
Sell
-13,500
Closed -$523K 483
2020
Q4
$523K Sell
13,500
-8,500
-39% -$304K ﹤0.01% 408
2020
Q3
$634K Buy
+22,000
New +$619K ﹤0.01% 329

Other funds holding CTVA

Brookfield Corp's CTVA Position: Q3 2023 in Review

Brookfield Corp sold out of Corteva (CTVA) in Q3 2023, closing a stake of 17,319 shares — an estimated $992K sold.

Brookfield Corp first reported a position in CTVA in Q3 2020 and held it in 8 quarters. The position peaked at $9.27M in Q1 2023. 1,194 funds tracked by Wall St. Rank hold CTVA as of Q3 2023.

  • Brookfield Corp reported no remaining Corteva position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 17,319 Corteva shares in Q3 2023, an estimated $992K.
  • Brookfield Corp first reported a position in Corteva in Q3 2020 and held it in 8 quarters.
  • Brookfield Corp's Corteva position peaked at $9.27M in Q1 2023.
  • 1,194 funds tracked by Wall St. Rank held Corteva as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.